Drug intelligence / Profile preview

desipramine + propranolol

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Desipramine + propranolol is a combination of two small molecule drugs, each with distinct mechanisms of action. Desipramine is a tricyclic antidepressant (TCA) primarily used to treat depression; it acts mainly by inhibiting the reuptake of norepinephrine and, to a lesser extent, serotonin in the central nervous system. Propranolol is a non-selective beta-adrenergic antagonist (beta blocker) used for hypertension, angina, arrhythmias, migraine prophylaxis, and other cardiovascular conditions. The combination does not have an established unique indication or brand formulation but may be co-administered in clinical practice for patients requiring both antidepressant and cardiovascular therapy. Pharmacodynamic interactions are possible; desipramine can antagonize some presynaptic effects of propranolol on noradrenaline release[2][3][4]. Both drugs are metabolized by hepatic enzymes and may interact at the level of drug metabolism[3][4].

02

Targets

ADRA2A (α2A)NET (Norepinephrine Transporter)ADRB2 (β2)SERT (Sodium-dependent serotonin transporter)ADRB1 (β1)

Beyond the preview

Go deeper on desipramine + propranolol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on desipramine + propranolol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call